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In recent decades, the elderly population in Brazil has grown rapidly, as has concern for the health of 
this population. Institutionalization in nursing homes has appeared as an alternative form of health care 
for frail elderly that live alone. The present study evaluated the pharmacotherapy and inappropriate 
drug prescriptions for institutionalized elderly patients living in long-term institutions in southeastern 
Brazil. This research was conducted at five institutions with a total sample of 151 individuals aged at 
least 60 years. Databases were used to identify drug interactions, defined daily dose and inappropriate 
prescriptions. The prevalence of drug intake among the elderly was 95.36%, and there were an average 
of 3.31 ± 1.80 drug prescriptions per individual. Based on Beers criteria, the prevalence of inappropriate 
prescriptions was 25.83%. In addition, 70.2% of prescriptions were prescribed at a higher dosage 
than the defined daily dose (ATC/WHO). Potential drug interactions were identified for 54.11% of 
prescriptions; 81.42% of these were of moderate severity. The main inappropriate drugs were prescribed 
for cardiovascular and nervous system problems. Institutionalized elderly individuals presented a high 
consumption and misuse of medications, requiring professional intervention to monitor prescriptions 
and improve the quality of service for this population.
Uniterms: Pharmacoepidemiology. Drug interactions. Beers criteria. Elderly/inappropriate use of 
medicines. Medicines//inappropriate use.
Nas últimas décadas, o número de idosos no Brasil cresceu rapidamente, bem como, a preocupação com 
a saúde desta parcela da população. Neste cenário, a institucionalização em casas de repouso aparece 
como uma alternativa para os cuidados com a saúde dos idosos debilitados ou que vivem sozinhos. 
O presente estudo avaliou a farmacoterapia e a prescrição inadequada para idosos que residem em 
instituições de longa permanência no sudeste do Brasil. Esta pesquisa foi realizada em cinco instituições, 
totalizando uma amostra de 151 indivíduos com idade a partir de 60 anos. O banco de dados foi analisado 
para identificação de interações medicamentosas, dose diária definida e critérios de Beers. Dentre os 
indivíduos avaliados, 95,36% consomem algum tipo de medicamento, sendo 3,31 ± 1,80 medicamentos 
prescritos por indivíduo. Com base nos critérios de Beers, a prevalência de prescrições inapropriadas foi 
de 25,83%, sendo também encontradas 70,2% das prescrições com doses superiores à dose diária definida  
(ATC/WHO). Interações medicamentosas potenciais estavam presentes em 54,11% das prescrições, sendo 
81,42% com grau moderado de gravidade. Os principais medicamentos inapropriados foram prescritos para 
problemas cardiovasculares e do sistema nervoso. Os idosos institucionalizados apresentam alto consumo e 
uso inadequado de medicamentos, sendo necessária a intervenção profissional para monitorar as prescrições 
médicas e melhorar a qualidade do serviço de distribuição de medicamentos a esta parte da população.
Unitermos: Farmacoepidemiologia. Interações medicamentosas. Critérios de Beers. Idosos/uso 
inapropriado de medicamentos. Medicamentos/uso inapropriado.
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INTRODUCTION
The Brazilian elderly population has grown 
steadily in recent decades due to substantial changes in 
contemporary society. The first significant change was 
the increase in life expectancy by medical advances and 
increased access to public health and sanitation, which 
occurred between the 1940s and 1970s (Flores, Mengue, 
2005; Nóbrega, Karnikowski, 2005; Chaimowicz, 
Greco, 1999). The second important change was the 
introduction of the contraceptive pill in the 1960s and 
the advent of family planning, which led to a significant 
decline in fertility. These factors led to an increase in the 
population 60 years of age or older, considered elderly in 
developing countries. It was estimated that in 2025, the 
Brazilian population will be 12% elderly and will have the 
sixth largest elderly population in the world by absolute 
numbers (Nóbrega, Karnikowski, 2005; Loyola-Filho et 
al., 2005; Coelho-Filho et al., 2004; Chaimowicz, Greco, 
1999).
There is a high prevalence of health conditions 
in this age group that require chronic drug treatment, 
including cardiovascular disease, metabolic syndromes, 
neurodegenerative diseases and affective disorders 
(Chaimowicz, Greco, 1999). Elderly patients frequently 
have difficulty reading prescriptions, resulting in errors 
in drug intake and dosage (Nóbrega, Karnikowski, 
2005; Loyola-Filho et al., 2005; Almeida et al., 1999). 
Furthermore, most elderly patients have comorbid 
ailments, which require the use of several medications. 
This can lead to potentially inappropriate or excessive 
drug usage (polypharmacy) and puts them at risk for drug 
interactions (Medeiros-Souza et al., 2007; Berenbeim, 
2002). In Brazil, the prevalence of drug consumption 
among the elderly is above 80% across the country, which 
represents a great concern to health care services (Ribeiro 
et al., 2008; Flores, Benvegnú, 2008; Loyola-Filho et al., 
2005; Chaimowicz, Greco, 1999).
The main challenge of pharmacotherapy for the 
elderly is the decrease in metabolic competence, which 
requires specific knowledge about the pharmacokinetics 
and pharmacodynamics of any medications prescribed 
to a patient (Chaimowicz, Greco, 1999). A lack of 
evaluation of medical prescriptions for elderly patients 
increases the risk of adverse reactions and iatrogenic 
diseases (Pereira et al., 2004). Prescription of potentially 
inappropriate medications to older people is highly 
prevalent in the United States and Europe, ranging from 
12% in community-dwelling elderly to 40% in nursing 
home residents (Gallagher et al., 2007). The main solution 
to avoid inappropriate treatment or irregular dosage 
depends on the advising and monitoring actions of health 
professionals during the pharmacotherapy (Ribeiro et al., 
2008; Pereira et al., 2004; Romano-Lieber et al., 2002).
Institutionalization in nursing homes is a healthcare 
option for older patients, but high occupancy rates, long 
waiting lists and bed scarcity make the institutionalization 
process in Brazil difficult (Chaimowicz, Greco, 1999). In 
addition to these problems, institutionalization in Brazil is 
linked to the outbreak of comorbidities such as immobility, 
emotional instability, social isolation, loss of autonomy 
and cognitive losses (Del Duca et al., 2012; Converso, 
Iartelli, 2007). In this context, institutionalization itself 
seems to be a health risk factor for the elderly, requiring 
specialized care, support and health services to prevent 
new diseases or worsening of physical and mental health 
problems (Gonçalves et al., 2008; Chaimowicz, Greco, 
1999).
The presence of a multidisciplinary team specializing 
in the assistance of elderly patients could reduce 
problems related to drug therapy and prevent iatrogenic 
diseases. Optimizing drug treatment for older patients is 
challenging; however, the analysis of pharmacotherapy 
prescribed for the elderly is fundamental to the success 
of the treatment (Gallagher et al., 2007). This study 
evaluates the pharmacotherapy used by institutionalized 
elderly patients from five southeastern Brazil long-term 
institutions (LTIs) to determine the prescription quality 
and promote the rational use of medication.
MATERIAL AND METHODS
This work was a descriptive transversal study 
that determined the qualitative and quantitative profile 
of prescription drugs used by 151 institutionalized 
individuals over the age of 60. The patients were located 
in five long-term institutions for the elderly in southeastern 
Brazil: Asilo de Idosos (Curvelo-MG), in Asilo Pão de 
Santo Antônio and Asilo Frederico Ozanan (Diamantina-
MG), Lar das Damas de Caridade e Asilo São Vicente de 
Paulo (Montes Claros-MG). This study was conducted 
during the year 2010. Data collection was performed by 
analysis of patients’ medical prescriptions and medical 
records from the institutions. This research project was 
approved by the Ethics in Research Committee of the 
State University of Montes Claros on the register number 
1250/2008.
The database of patient information was subjected 
to a pretreatment system for insertion into a MySQL 
database (version 5.1.37) that employed SQL queries for 
patient, age, gender, prescription drugs, dose and dosage 
regimen. The drug names were classified using the manual 
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of Brazilian Nonproprietary Names (DCB). The active 
principle components were organized according to the 
Anatomical Therapeutic Chemical (ATC) Classification 
System of the World Health Organization (WHO) (WHO, 
2011). The prescription drugs were evaluated according 
to the Brazilian National List of Essential Medicines 
(RENAME). The prescription dose was compared to the 
defined daily dose (DDD) as proposed by the World Health 
Organization-WHO (WHO, 2011; Brazil, 2008). The 
therapy, dose and dosage regimen were evaluated using 
Beers criteria for potentially inappropriate medication use 
in older adults (Fick et al., 2003; The American Geriatrics 
Society Beers Criteria Update Expert Panel, 2012). 
Drug interactions were assessed in pairs and classified 
by severity (major, moderate or minor) according to the 
website www.drugs.com, which included the database 
sources Micromedex™, Cerner Multum™ and Wolters 
Kluwer™.
For the evaluation of statistical data, R project 
software (version 2.11.1) was used. The normality of the 
distributions was tested with the Shapiro-Wilk normality 
test (Royston, 1982). The data were expressed as the mean 
± standard deviation. The groups were compared with 
Pearson’s Chi-squared test. When the matrix was 2x2, the 
Yates’ continuity correction was carried out.
RESULTS
The LTI population was composed of 62.91% 
(n=95) female and 37.09% (n=56) male patients with 
a medicine intake prevalence of 95.36% (n=146). The 
average age of the elderly population was 76.69 ± 10.97, 
with no difference between the male (73.68 ± 7.79) and 
female (78.36 ± 12.11) population age. The average 
number of medications consumed per individual was 3.31 
± 1.80 (3.40 ± 1.82 for females, 3.19 ± 1.76 for males). 
In addition, 66.20% (n=500) of medications were present 
in the RENAME list, and 52.95% were prescribed under 
the generic name. Only 38.4% of medications prescribed 
were in agreement with Anatomical Therapeutic Chemical 
Classification System of the World Health Organization.
The anatomical group evaluation of institutionalized 
elderly patients revealed that nervous system medicines 
(80.79%) were the most prescribed in southeastern Brazil 
LTIs, follow by cardiovascular medicines (58.28%). A 
closer look at the pharmacological groups showed that 
psycholeptics (42.38%) and ACE inhibitors (35.10%) 
were prevalent drug classes. In addition, consumption 
of diuretics (31.13%) and psychoanaleptics (26.49%) 
was common. Consumption of nervous system drugs 
and antithrombotic agents presented significant gender 
differences (p<0.05, chi-squared test with Yates’ 
correction). The prescription profile of this group of 
institutionalized elderly patients is detailed in table I.
An additional analysis was performed to evaluate 
drug interactions in prescriptions for the elderly. The 
analysis found a total of 226 occurrences with an average 
of 1.5 ± 2.55 drug interactions per prescription. In all, 3.1% 
were major cases, 81.42% were moderate cases and 15.49% 
were minor cases of interaction. The overall prevalence of 
drug interactions was 54.11% (n=79). These were greater 
in female patients (65.93%) than male patients (34.09%) 
(p<0.05, Pearson’s Chi-squared test). The evaluation of drug 
interactions across anatomical groups revealed that 39.74% 
of combinations were cardiovascular medicines with 
nervous system medicines, closely followed by interactions 
between two different cardiovascular medicines at 36.42%. 
Pharmacological group interactions most frequently 
occurred between ACE inhibitors and antithrombotic 
agents (12.58%), followed by interactions between ACE 
inhibitors and diuretics (9.27%). Interactions between 
cardiovascular system medicines and blood/blood forming 
organs presented significant gender differences (p<0.05, 
chi-squared test with Yates’ correction). The profile of drug 
interactions in this group of institutionalized elderly patients 
is detailed in Table II.
Medical prescription evaluations that look for the 
presence of inappropriate medication are an important 
indicator of prescription quality. First, Beers Criteria was 
utilized to classify inappropriate medications prescribed 
to institutionalized elderly individuals. Inappropriate 
prescriptions showed a prevalence of 63.01% in the 
institutionalized elderly population, and these were 
greater in elderly females (p<0.05, chi-squared test with 
Yates’ correction). These prescriptions for the elderly 
represented 26.38% of all medications prescribed. The 
main pharmacological group inappropriately prescribed 
was psycholeptics (50.33%), followed by cardiac 
medicines (14.56%) and endocrine drugs (4.63%). In a 
second analysis, inappropriate medication was evaluated 
by the DDD, which is the assumed average maintenance 
dose per day for a drug used for its main indication in 
adults. The prescription evaluations showed that 70.2% 
of the institutionalized elderly patients had an intake 
dosage higher than the DDD, which represented 38.4% of 
the total medication prescribed. When Beers List and the 
DDD were evaluated together, 52.74% of elderly patients 
presented both types of inappropriate medications in their 
prescriptions, with no difference between female and male 
patients (p>0.05, chi-squared test).
Regarding drug interactions, in 32% of occurrences, 
at least one drug belonged to Beers List. In 14.67% of 
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TABLE I - Drug prescriptions for elderly patients in Brazilian long-term institutions (Southeastern Brazil, 2010)
Prevalence 
(%)
Female 
(%)
Male 
(%)
P-value
Anatomical group
Nervous system 80.79 71.58 96.43 0.00***
Cardiovascular system 58.28 58.95 57.14 0.96
Alimentary tract and metabolism 37.09 40.00 32.14 0.43
Blood and blood forming organs 24.50 20.00 32.14 0.14
Systemic hormonal preparations. excl. sex hormones and insulin 8.61 10.53 5.36 0.43
Skeleton-muscular system 3.97 4.21 3.57 0.81
Respiratory system 3.31 3.16 3.57 0.74
Dermatologicals 1.99 2.11 1.79 0.64
Anti-infectives for systemic use 0.66 1.05 0.00 0.78
Sensory organs 0.66 1.05 0.00 0.78
Pharmacological group
Psycholeptics 42.38 47.37 33.93 0.15
ACE inhibitors 35.10 31.58 41.07 0.32
Diuretics 31.13 31.58 30.36 0.98
Psychoanaleptics 26.49 28.42 23.21 0.61
Antiepileptics 19.21 16.84 23.21 0.46
Antithrombotic agents 19.21 13.68 28.57 0.04*
Each parameter was individually analyzed by a chi-squared test with Yates’ correction. Differences between the observed and 
expected frequencies were considered significant when p<0.05 (*) or p<0.001 (***).
TABLE II - Drug interactions for elderly patients in Brazilian long-term institutions (Southeastern Brazil, 2010)
Prevalence 
(%)
Female 
(%)
Male 
(%)
P-value
Anatomical group     
Cardiovascular system & nervous system 39.74 41.05 37.50 0.80
Cardiovascular system & cardiovascular system 36.42 42.11 26.79 0.09
Cardiovascular system & blood and blood forming organs 18.54 10.53 32.14 0.00**
Nervous system & nervous system 17.22 22.11 8.93 0.06
Cardiovascular system & alimentary tract and metabolism 7.95 7.37 8.93 0.98
Pharmacological group     
Ace inhibitors & antithrombotic agents 12.58 9.47 17.86 0.21
Ace inhibitors & diuretics 9.27 5.26 16.07 0.05
Ace inhibitors & antidepressants 6.62 5.26 8.93 0.59
Diuretics & Antithrombotic agents 5.30 4.21 7.14 0.69
Diuretics & cardiac glycosides 4.64 5.26 3.57 0.95
Each parameter was individually analyzed by a chi-squared test with Yates’ correction. Differences between the observed and 
expected frequencies were considered significant when p<0.05 (*).
cases, both medications were inappropriate. Analysis of 
drug interactions and the DDD showed that 34.44% of 
prescriptions had at least one medication prescribed at 
a higher dose than the DDD. Finally, both medications 
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were inappropriate in 11.26% of occurrences. In both 
evaluations, gender differences were found (p<0.05, chi-
squared test). The profile of inappropriate medications in 
this group of institutionalized elderly patients is detailed 
in Table III.
An analysis of the chemical substances taken by 
institutionalized elderly patients shows that among the 
five most prescribed medicines, four are substances that 
act on the cardiovascular system. This is in contrast to 
the analysis by pharmacological group. Captopril is 
prescribed to 31.13% of institutionalized elderly patients; 
however, the high prevalence of risperidone (20.53%) and 
haloperidol (9.93%) is relevant for this group of patients. 
Five of the six most common drug interactions found in 
this analysis involve the most prescribed drugs for the 
elderly, in accordance with the pharmacological group 
analysis. Captopril and furosemide are major sources 
of the drug interactions found in this study. Likewise, 
we find that digoxin (7.95%) is the most inappropriate 
medication prescribed for these patients, followed by a 
food supplement of ferrous sulfate (6.62%), thioridazine 
(5.96%), lorazepam (3.31%) and diazepam (1.99%). The 
profile of chemical substances found in this group of 
institutionalized elderly is detailed in Table IV.
DISCUSSION
This work presented a detailed profile of medication 
consumption and inappropriate medication use in 
elderly patients in long-term institutions in southeastern 
Brazil. The sample population we evaluated had a 
representative age distribution with an average age of 
approximately 75 years; similar numbers were reported 
in the Federal District-DF, Fortaleza-CE and Rio Grande-
RS (Gonçalves et al., 2008; Menezes, Marucci, 2005). In 
long-term institutions in southeastern Brazil, women were 
predominant; however, regional differences influenced the 
prevalence of gender, with women being more prevalent 
in Fortaleza-CE, Rio Grande-RS and Belo Horizonte-MG 
(69.2%, 75.0% and 81.0%, respectively) and men being 
more prevalent in the Federal District (58.8%) (Gonçalves 
et al., 2008; Menezes, Marucci, 2005; Chaimowicz, 
Greco, 1999).
In this report, the prevalence of prescription 
medications in southeastern Brazil (95.36%) was greater 
than in northeastern Brazil (87.2%). The prevalence was 
also greater than for community-dwelling elderly reported 
in Belo Horizonte-MG (72.1%), Bambui-MG (79.7%), 
Diamantina-MG (80.3%), Rio de Janeiro-RJ (85%), Porto 
TABLE III - Inappropriate medication prescribed for elderly patients in Brazilian long-term institutions (Southeastern Brazil, 2010)
Prevalence 
(%)
Female 
(%)
Male 
(%)
P-value
Beers list
Yes 63.01 90.28 50.00 0.02*
No 36.99 9.72 50.00
Dosage higher than DDD
Yes 70.20 74.74 62.50 0.16
No 29.80 25.26 37.50
Dosage higher than DDD and Beers list
Yes 52.74 57.61 44.44 0.17
No 47.26 42.39 55.56
Drug interaction and Beers list
Both 14.67 15.69 12.5 0.09
Only one 32 39.22 16.67
None 53.33 45.09 70.83
Drug interaction and dosage higher than DDD
Both 11.26 14.74 5.36 0.00**
Only one 34.44 42.11 21.43
None 54.30 43.16 73.21
Each parameter was individually analyzed by a chi-squared test. Differences between the observed and expected frequencies was 
considered significant when p<0.05 (*).
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Alegre-RS (85.8%) and Fortaleza-CE (80.3%) (Pinto et 
al., 2012; Venturini et al., 2011; Rozenfeld et al., 2008; 
Aguiar et al., 2008; Loyola-Filho et al., 2005; Coelho-
Filho et al., 2004). In the southeast, the average of three 
medications per institutionalized elderly patient was also 
higher than for community-dwelling elderly; in cities 
Belo Horizonte-MG, Fortaleza-CE and Santa Rosa-RS, 
the average prescription number ranged from 2.18 to 2.71 
medications per elderly patient (Flores, Benvegnú, 2008; 
Loyola-Filho et al., 2005b; Coelho-Filho et al., 2004). 
Corroborating these findings, a cross-sectional survey 
performed in São José dos Campos-SP demonstrated that 
institutionalized elderly presented a higher prevalence 
of medication use and polypharmacy (92% and 3.2 
medications, respectively) when compared to community-
dwelling groups (80.7% and 1.8 medications, respectively) 
(Marchini et al., 2011). These data suggested that 
institutionalized elderly were more exposed to the risks 
of inappropriate medications than community-dwelling 
groups.
Nervous system drugs represented four fifths of the 
anatomical medicine groups consumed by institutionalized 
elderly. Lucchetti et al. (2010) reported that 58.9% of 
institutionalized elderly patients were prescribed nervous 
TABLE IV - Chemical substances prescribed for elderly patients in Brazilian long-term institutions (Southeastern Brazil, 2010)
Prevalence 
(%)
Female 
(%)
Male 
(%)
P-value
Substances most prescribed     
Captopril 31.13 26.32 39.29 0.14
Risperidone 20.53 23.16 16.07 0.40
Acetylsalicylic acid 19.21 14.74 26.79 0.11
Furosemide 17.22 16.84 17.86 0.95
Hydrochlorothiazide 14.57 14.74 14.29 0.87
Calcium carbonate 11.26 14.74 5.36 0.13
Haloperidol 9.93 13.68 3.57 0.04*
Amlodipine 8.61 9.47 7.14 0.85
Omeprazole 8.61 9.47 7.14 0.85
Beers Criteria     
Risperidone 20.53 23.16 16.07 0.30
Thioridazine 9.93 10.53 8.93 0.97
Haloperidol 9,93 13.68 3.57 0.04*
Digoxin 7.95 10.53 3.57 0.22
Phenobarbital 5.30 6.32 3.57 0.46
Chlorpromazine 5.30 6.32 3.57 0.46
Clonazepam 4.64 4.21 5.38 0.75
Glyburide 3.97 5.26 1.79 0.29
Nifedipine 3.31 5.26 0.00 0.20
Lorazepam 3.31 5.26 0.00 0.20
Drug interactions
Captopril and acetylsalicylic acid 9.93 6.32 16.07 0.10
Captopril and hydrochlorothiazide 7.95 6.32 10.71 0.51
Captopril and furosemide 6.62 4.21 10.71 0.22
Furosemide and acetylsalicylic acid 5.96 2.11 12.50 0.02*
Furosemide and digoxin 5.96 1.05 16.07 0.00***
Captopril and calcium carbonate 2.65 4.21 0.00 0.30
Each parameter was individually analyzed by a chi-squared test with Yates’ correction. Differences between the observed and 
expected frequencies were considered significant when p<0.05 (*) or p<0.001 (***).
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system medications; this reported prevalence was lower 
than found in LTIs of southeastern Brazil. Risperidone and 
haloperidol were the most prescribed chemical substances, 
followed by antidepressants and benzodiazepines 
(Lucchetti et al., 2010). Likewise, psycholeptics were on 
the top of the list in southeastern Brazil LTIs, which were 
also characterized by a high consumption of risperidone 
and haloperidol. Around the country, the prevalence of 
psychotropic drug use among non-institutionalized elderly 
ranged between 15% and 25%, which is lower than the 
prevalence found in southeastern Brazil LTIs (Venturini 
et al., 2011; Rozenfeld et al., 2008; Loyola-Filho et al., 
2005b; Coelho-Filho et al., 2004). In fact, Marchini et al. 
(2011) described that institutionalized elderly (59.3%) 
used psychotropic drugs more frequently than community-
dwelling elderly (14.7%) (Marchini et al., 2011). The 
frequency of psychotropic drug consumption was an 
indicator of the high psychiatric component of LTIs in 
southeastern Brazil.
Cardiovascular agents are the most consumed 
medication by community-dwelling elderly in Brazil, with 
a prevalence that ranges from 30% to 60% of prescriptions; 
the prevalence is strongly related to regional features 
(Pinto et al., 2012; Venturini et al., 2011; Rozenfeld 
et al., 2008; Aguiar et al., 2008; Loyola-Filho et al., 
2005; Coelho-Filho et al., 2004). In the five long-term 
institutions studied, the prevalence of cardiovascular 
drug consumption is close to that of northeastern Brazil, 
where institutionalized elderly present a prevalence 
of 47.3%. The consumption of alimentary tract and 
metabolism agents are also similar (Aguiar et al., 2008). In 
southeastern Brazil LTIs, the consumption of medication 
related to heat problems is within the national rates, but the 
use of alimentary tract and metabolism agents is lower than 
in cities like Rio de Janeiro-RJ and Fortaleza-CE; their 
use in the southeast is similar to the use reported in Belo 
Horizonte (Rozenfeld et al., 2008; Loyola-Filho et al., 
2005b; Coelho-Filho et al., 2004). In the first inappropriate 
prescription evaluation, we look for the rate of prescription 
drug interactions. In institutionalized elderly, 54.11% of 
the prescriptions present some drug interaction, which is 
higher than found in community-dwelling elderly from 
Diamantina-MG (45.8%) and Porto Alegre-RS (32.6% of 
men and 49.2% of women) (Pinto et al., 2012; Venturini et 
al., 2011). When we evaluate the pharmacological group 
and chemical substances, the main drug interactions occur 
between cardiac medications. This is compatible with 
observations in community-dwelling elderly around the 
country and is expected due to the prevalence of these 
drugs in prescriptions (Pinto et al., 2012; Venturini et 
al., 2011). Although these combinations are common in 
pharmacotherapy, concomitant administration of these 
agents may lead to hypotension and hypovolemia. To 
prevent this type of iatrogenic problem, teamwork between 
physicians and pharmacists is required for intervention and 
revision of the prescriptions. 
Another important indicator of medical prescription 
quality is provided by Beers criteria, which lists the 
primary inappropriate drugs for the elderly. Almost two-
thirds of individuals in southeastern Brazil long-term 
institutions consume inappropriate medication according 
to Beers criteria, higher than the prevalence in northeastern 
Brazil long-term institutions. In part, the high amount of 
inappropriate medication use is due to the extension of the 
medications on Beers criteria in 2012. In the community-
dwelling elderly, the consumption of inappropriate 
medication by Beers criteria ranges between 10-30%, with 
psychotropic drugs being the most dangerous group (Pinto 
et al., 2012; Rozenfeld et al., 2008; Coelho-Filho et al., 
2004). Surprisingly, a great number of prescriptions are 
for dosage higher than the DDD, which is a serious risk for 
individual that already have reduced metabolic capacity.
In this study, efforts were made to avoid possible 
biases. The data collection procedure and forms were 
standardized, and collectors were trained. Nevertheless, 
this study was performed in only five long-term 
institutions; definitive conclusions about inappropriate 
use of medicines in other locations must be drawn with 
caution. The features of the sample collected were similar 
to others studies. For example, the number of women was 
higher than men. This was likely related to differences 
in lifespan between the genders. In our study, any brand 
name drugs were re-classified according the naming of 
ATC Classification System. For the evaluation of our data 
according to Beers criteria, the DDD and drug interactions, 
our analysis was limited to the databases provided by the 
current literature and the drugs.com database. However, 
reasoned that most important inappropriate use of 
medications and interactions were included in these 
databases.
This work provides valuable information about 
inappropriate prescription of medicines to elderly 
patients in LTIs and characterizes the current profile of 
medication use in southeastern Brazil. The high prevalence 
of inappropriate prescriptions found in institutionalized 
elderly patients is a strong indication of poor quality 
health services; the prevention and correction of these 
inadequacies requires the adoption of new practices and 
policies. We believe that the involvement of a pharmacist 
in nursing homes could help identify, prevent and 
resolve problems related to prescription medication, thus 
ensuring higher quality pharmacotherapy for the elderly. 
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In addition, prescription of generic drugs and those on 
the RENAME list allows access to medicines through the 
Brazilian health care system (SUS); thus, medicines can be 
purchased at more affordable prices and with guaranteed 
quality and interchangeability. In conclusion, an individual 
analysis of prescriptions is essential to prevent iatrogenic 
disease, promote the rational use of medicines and increase 
the quality of care in institutional environments.
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